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Activation of picornaviral IRESs by PTB shows differential
dependence on each PTB RNA-binding domain
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ABSTRACT
Polypyrimidine tract binding protein (PTB) is an RNA-binding protein with four RNA-binding domains (RBDs). It is a major
regulator of alternative splicing and also stimulates translation initiation at picornavirus IRESs (internal ribosome entry sites).
The sites of interaction of each RBD with two picornaviral IRESs have previously been mapped. To establish which RBD–IRES
interactions are essential for IRES activation, point mutations were introduced into the RNA-binding surface of each RBD. Three
such mutations were sufficient to inactivate RNA-binding by any one RBD, but the sites of the other three RBD–IRES
interactions remained unperturbed. Poliovirus IRES activation was abrogated by inactivation of RBD1, 2, or 4, but the RBD3-
IRES interaction was superfluous. Stimulation of the encephalomyocarditis virus IRES was reduced by inactivation of RBD1, 3,
or 4, and abrogated by mutation of RBD2, or both RBDs 3 and 4. Surprisingly, therefore, the binding of PTB in its normal
orientation does not guarantee IRES activation; three native RBDs are sufficient for correct binding but not for activation if the
missing RBD–IRES interaction is critical.
Keywords: tethered hydroxyl radical probing; poliovirus; encephalomyocarditis virus; IRES; RRM (RNA recognition motif); RBD
(RNA-binding domain)
INTRODUCTION
Polypyrimidine tract binding protein (PTB) has four RNA-
binding domains (RBDs), also known as RRMs (RNA
recognition motif), of the RNP1/RNP2 class (Oberstrass
et al. 2005; Auweter and Allain 2008), although these ele-
ments are rather atypical in their lack of aromatic residues.
PTB is a monomer in solution, but it has an extended con-
formation (Simpson et al. 2004; Monie et al. 2005), with
flexible linkers between RBDs 1 and 2 and between RBDs
2 and 3. In contrast, RBDs 3 and 4 are separated by a short
linker and seem to act as a pair or didomain (Oberstrass
et al. 2005). In addition to the prototypic species (PTB-1),
there are two isoforms resulting from alternative splicing
(Wollerton et al. 2001) which differ from PTB-1 by the
insertion of 19 (PTB-2) or 26 amino acids (PTB-4) in the
linker between RBDs2 and 3.
PTB is predominantly nuclear, where its main function is
as a regulator of alternative splicing of many pre-mRNAs
(Spellman et al. 2005; Auweter and Allain 2008). However,
PTB (which is also known as hnRNP I) is a shuttling protein
(Ghetti et al. 1992), and there is a significant amount of it in
the cytoplasm. An influence of PTB on several different
cytoplasmic events has been reported (for review, see Sawicka
et al. 2008), and the best studied case is the stimulation of
translation initiation dependent on picornavirus internal
ribosome entry sites/segments (IRESs) (Jackson and Kaminski
1995).
The PTB requirement for picornavirus IRESs varies quite
widely according to the species. Themajority of picornavirus
IRESs are generally classified into twomain groups (Alexander
et al. 1994; Jackson and Kaminski 1995): type I IRESs,
exemplified by enteroviruses (e.g., polioviruses) and human
rhinoviruses, and type II, exemplified by encephalomyo-
carditis virus (EMCV) and foot-and-mouth-disease virus
(FMDV). There is quite strong conservation of primary
sequence and even stronger conservation of secondary
structure within each group but very little similarity between
the two groups. PTB is absolutely required for internal
initiation on all the type I IRESs that have been tested so
far, namely polioviruses (PV) and human rhinovirus-2
(Hunt and Jackson 1999), but type II picornavirus IRESs
show more variability in their response to PTB. The FMDV
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IRES shows strong dependency on PTB (Niepmann 1996;
Pilipenko et al. 2000), but for the encephalomyocarditis virus
(EMCV) IRES, the PTB requirement is conditional on the
nature of the reporter and the IRES variant used (Kaminski
and Jackson 1998).
The binding sites of PTB on its pre-mRNA targets and
on IRESs have been mapped by a combination of gel-shift
and UV-cross-linking assays with mutagenesis of the puta-
tive interaction sites. However, these approaches provide no
information on the orientation of the PTB binding to its
target RNAs—the question of which RBD binds to which
site on the RNA.We have recently generated a battery of PTB
mutants, each with a single cysteine positioned at sites
flanking the actual RNA-binding surface of each RBD, and
we have used these derivatives in tethered hydroxyl radical
probing tomap the orientation of PTB binding to the EMCV
and poliovirus IRESs (Kafasla et al. 2009, 2010). The results
showed a very different pattern of PTB interaction with these
two IRESs. The core EMCV IRES bound a single PTB, with
RBDs1 and 2 binding near the 39-end of the IRES and RBDs3
and 4 interacting with the 59-end of the core IRES (Kafasla
et al. 2009). This suggested that PTB bindingwould constrain
the flexibility of the three-dimensional structure of the IRES
and probably help to stabilize the optimum structure for
internal initiation. In contrast, PTB binding to the poliovirus
IRES was much more localized and was confined to the base
of just one (Domain V) of the five irregular stem–loop
structures present in the core IRES (Kafasla et al. 2010). In
this case, the PTB binding site partially overlapped with the
binding site of initiation factor eIF4G on the IRES, and the
presence of PTB caused the position and orientation of eIF4G
binding to be subtly modified.
While this tethered hydroxyl radical probing has provided
considerable insight into how PTB interacts with these
target RNAs, it does not answer the question of whether
the interactions of all four RBDs with the target are essential
for the biological activity of PTB. To address this issue, we
have made several point mutations in the RNA-binding
surface of each RBD. We found that three amino acid
substitutions in the b2- or b4-strand suffice to disrupt the
interaction of the mutated RBD with the EMCV (strain R)
and poliovirus type 1 Mahoney (PV-1) IRESs, without al-
tering the sites of interaction of the other three RBDs with
these IRESs. These mutants were then tested in translation
assays to assess the relative importance of each RBD for the
PTB-dependent activation of the two viral IRESs.
RESULTS
Mutants generated
This investigation had four distinct steps: (1) generating the
point mutations in the RNA-binding surface of each RBD;
(2) verifying that the RNA-binding potential of the mutated
RBDs has, indeed, been destroyed and determining which
mutations are the most effective in this aim; (3) verifying
that the interaction of the other three (non-mutated) RBDs
with the target RNAhas not been significantly perturbed; and
(4) assaying the biological activity of the mutants in each
RBD to assess which interactions are the most critical for this
activity.
All the mutants were made in the background of a PTB-1
construct with a deletion of the N-terminal domain (NTD)
(amino acids 1–54), which has nuclear import and export
signals but is not involved in the interaction of PTB with
RNA (Auweter and Allain 2008). This parent DNTD–PTB
construct, hereafter designated PTB9, also has an N-terminal
His-tag, andwhen the two remaining cysteine residues (C250
and C251 in RBD2) were replaced by serines (Fig. 1C), it
resulted in the Cys-less PTB9 construct which is used as the
control in tethered hydroxyl radical probing assays of the
interaction of each RBD with the target RNA, as in our
previous work (Kafasla et al. 2009, 2010).
The choice of sites for mutation was based on the NMR
structures of each RBD complexed with an oligonucleotide
ligand (Oberstrass et al. 2005), which identified the amino
acid residues (colored red in Fig. 1A) in intimate contact
with the RNA. The 29 mutated sites are listed in Figure 1B,
with the most effective combinations for disrupting RNA-
binding highlighted by an asterisk; all except two of these
mutations were at positions colored red in Figure 1A. Single
mutations were made in the b1-strand of each RBD (apart
fromRBD1), but nomutations weremade in theb3-strands
because Oberstrass et al. (2005) reported that this strand
does not contribute to the RNA-binding of any of the
four RBDs. Groups of 2 or 3 mutations were introduced
by multiple site-directed mutagenesis into the b2- and
b4-strands in each RBD and in the b4–b5 linker of RBDs2
and 3.
For the first RBD examined (RBD2), we constructed
several combinations of the four mutation groups (a–d), in
the expectation that complete inactivation of RNA-binding
would require mutations in more than one b strand. How-
ever, this proved unnecessary, because the group bmutations
were as effective as any combination, as shown in the next
section. Moreover, combining mutation groups had the
disadvantage that the increased number of mutations gen-
erally resulted inmore recombinant protein appearing in the
bacterial inclusion bodies (although there was always suffi-
cient soluble protein toworkwith). For the other three RBDs,
we, therefore, made a preliminary screen to identify which
single mutation group was the most effective at disrupting
the RBD–IRES interaction and then tested whether pairwise
combinations of this mutation group with others in the same
RBD were even more effective. We also made a mutant
(designated D1) in which the whole RBD1 of PTB9 (amino
acids 55–139 of PTB-1) was replaced with a 7-residue flexible
segment (GSGSGSG).
Tethered hydroxyl radical probing was used to verify
whether the RNA-binding potential of the mutated RBD
Mechanism of picornavirus IRES activation by PTB
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had, indeed, been disrupted. To this end, the pointmutations
in the RNA-binding surface of a particular RBDwere initially
put into the background of a single cysteine derivative where
the cysteine is located in the same RBD. From our library of
16 single cysteine PTB9 derivatives which all reacted effi-
ciently with Fe(II)-BABE (Kafasla et al. 2009), we selected six
for these assays—one in each of RBDs2 and 3 and two in each
of RBDs1 and 4 (Fig. 1C). These six derivatives were chosen
because they gave strong cleavages with both viral IRESs
(Kafasla et al. 2009, 2010). The designation of such mutants
takes the form C2-ab (for example) signifying that the a and
b groups of point mutations in RBD2 were combined with
a single cysteine derivative (D284C) with the Cys in RBD2
(hence, the designation C2).
Tethered hydroxyl radical probing was likewise used to
test whether disruption of the RNA-binding potential of
a particular RBD perturbed the interactions of the other
three RBDs with the IRESs. For this purpose, up to two
additional cysteines (Fig. 1C) were introduced into other
(non-mutated) RBDs (one cysteine per RBD). The desig-
nation of these derivatives takes the form C2C3C4A-b (for
example), indicating that the group b mutations and the
cysteine substitution (D284C) in RBD2 were combined
with a cysteine (N395C) in RBD3 and another (E518C) in
RBD4.
Verifying the disruption of the RNA-binding potential
of the mutated RBDs
Following conjugation of the mutant proteins with Fe(II)-
BABE, tethered hydroxyl radical probing was used to de-
termine whether the mutations in each RBD had disrupted
its interactionswith the two viral IRESs. For the EMCV IRES,
we used the whole 59 UTR downstream from the poly(C)
tract as the target (Duke et al. 1992), because this binds two
PTB molecules, whereas the minimal core IRES, which has
Domain H at its 59-end (Fig. 2B; Jang and Wimmer 1990),
binds only one (Kafasla et al. 2009). All the analyses included
assays with the single cysteine derivatives (C1–C4) (see Fig.
1C) in the background of wild-type (unmutated) RNA-
binding surfaces of all four RBDs. These serve as reference
standards, showing the sites of cleavage generated by Fe(II)-
BABE conjugated at these positions. In addition, an assay with
C-less PTB9 (which had been taken through the conjugation
step) was always included as a background control. A band
in the lanes with the single cysteine reference standards was
considered to be a genuine cleavage product due to hydroxyl
radical action only if it was distinctly more intense than the
corresponding band in the C-less control lane (Kafasla et al.
2009). Mutations in the RNA-binding surface of a particular
RBD were considered to have disrupted its RNA-binding
FIGURE 1. Generation of PTB9 mutants to disrupt the RNA-binding potential of individual RBDs. (A) Sequence alignment of the four RBDs of
PTB, adapted from Oberstrass et al. (2005), with the same color coding: amino acid residues interacting with the RNA in red; residues in black
and gray are located in the b-sheets, with those in gray pointing toward the hydrophobic core of the RBD; and residues in yellow are in the
a-helices. (B) The mutation groups introduced into each RBD to disrupt RNA-binding. Their location in each RBD is given, and the asterisks
identify the most effective inactivating mutation group in each RBD. (C) Schematic representation of PTB1 showing the positions of the four
RBDs, the first (N-terminal) 54 amino acids that were deleted in PTB9 (gray shading) and the native cysteines of PTB (in gray) which were
substituted with serines in PTB9. The positions of the single cysteines introduced into each RBD and used as reference standards are also shown,
and the actual amino acid replacements are listed.
Kafasla et al.
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potential if all the expected cleavages generated by the
reference Cys derivative in this RBD disappeared at all three
PTB binding sites (one in the PV-1 IRES and two in the
EMCV probe).
Cleavage sites were detected by reverse transcription using
primers that bind to the sites shown in Figure 2B (EMCV
IRES) and Figure 2D (PV-1 IRES). Representative auto-
radiographs of full-length gels showing the primer extension
analyses of cleavage sites in the EMCV IRES and PV-1 IRES,
using one particular primer in each case, are presented in
Figure 2, A and C, respectively. Figure 3 shows the parts of
gels (with the same and other primers) where the main
FIGURE 2. Representative primer extension analyses of directed hydroxyl radical probing of the EMCV and PV IRESs with Fe(II)-BABE PTB9
mutants. (A) Directed hydroxyl radical probing was carried out under standard conditions with the designated Fe(II)-PTB9 derivatives, and the
cleavage products were analyzed by primer extension using EMCVpr1 to examine nt 300–375 of the EMCV IRES. Sites of hydroxyl radical
cleavages are indicated by vertical lines to the left of each reference standard (control) lane. Lanes T,G are from sequencing ladders using the same
primer. (B,D) Schematic representation of the orientation of PTB binding to the EMCV IRES (panel B), adapted from Kafasla et al. (2009), and to
the PV-1 IRES (panel D), adapted from Kafasla et al. (2010). RBD1 is in transparent green, pink denotes RBD2, and the RBD3 + 4 didomain is in
transparent blue. The same color coding is used to show the sites of cleavage by the designated Fe(II)-PTB9 reference standard derivatives.
Cleavages are classified as strong (large filled arrowhead), medium (medium filled arrowhead), or weak (smallest open arrowhead). For clarity,
only the cleavages used in the present study as reference standards are shown; for complete cleavage site maps, see Kafasla et al. (2009, 2010). The
annealing positions of the primers used for the primer extension analyses in the present study are also shown. (C) Tethered hydroxyl radical
probing of PV IRES RNA with the specified Fe(II)-PTB9 mutants, using primer PVpr6 for primer extension analysis of nt 445–555. Cleavage sites
are highlighted by vertical lines, as in panel A.
Mechanism of picornavirus IRES activation by PTB
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cleavage products generated by Fe(II)–BABE conjugated to
different RBDs are found.
These data show that the mutations in group m in the
RBD1 b4-strand are sufficient to disrupt its binding to
Domains F (nt 356) and K (nt 742) of the EMCV IRES and
Domain V (nt 479) of the PV-1 IRES (Fig. 3A,B,I); the ml
mutation combination was not significantly different from
m alone. Similarly the group b mutations in the b2-strand
inactivate interaction of RBD2 with Domains F (nt 350) and
K (nt 739) of the EMCV IRES (Fig. 2A, cf. lanes 10–12 and 3;
Fig. 3C,D), in addition to Domain V of the PV IRES (Fig. 2C,
cf. lanes 10–12 and 3; Fig. 3J), andwere as effective as the abcd
combination (Fig. 3C,D,J).
For RBD3, the mutation group f in the b2-strand clearly
disrupted the strong interaction of RBD3 with Domain D
(nt 300) and Domain H (nt 420) of the EMCV IRES, and we
saw no evidence that the ef and fg combinations were more
effective (Fig. 2A, cf. lanes 13–16 and 4; Fig. 3E,F). Mutation
group f in RBD3 also appeared to disrupt the interactionwith
the PV-1 IRES (Fig. 3K), although this is harder to judge
because Fe(II)-N395C PTB9 generates no
strong cleavages in the PV IRES but only
one somewhat variable medium-weak
cut and a few other extremely weak
cleavages (Kafasla et al. 2010). Finally,
the mutation group k in the b4-strand
disrupted the interaction of RBD4 with
the Domain E–F linker (nt 342) and
Domain G (nt 385) of the EMCV IRES
and the Domain IV–V linker in the PV-1
IRES; at all three sites, it appeared to be
no less effective than the ik combina-
tion (Fig. 2A, cf. lanes 16–18 and 6; Fig.
3G,H,L) or the jk combination (data not
shown).
Importantly, there was no target site
specificity with respect to which muta-
tions were the most effective in abrogat-
ing the interactions of each RBD with
these IRESs. This suggests that them, b, f,
and k mutations will successfully disrupt
the interactions of PTB RBDs1, 2, 3, or 4,
respectively, with any target RNA.
Testing whether the binding
of the other three (non-mutated)
RBDs is maintained
In the next step, the most effective
inactivatingmutations in the RNA-bind-
ing surface of each RBD were combined
with mutants having single cysteines
in the other RBDs to enable the use of
tethered hydroxyl radical probing for
evaluating whether the interactions of
these non-mutated RBDs with the IRESs had been main-
tained. For these purposes, we examined the interactions
with both IRESs, and a representative set of results is shown
in Figure 4, which includes a tabulated semi-quantitative
summary of the consensus outcome of these and numerous
other similar experiments. Both PTB binding sites in the
EMCV IRESwere examined, but in order to keep the figure to
a manageable size, Figure 4 shows only the autoradiographs
for the 59-proximal binding site.
The general conclusion from the results shown in Figures
2A,C and 4, plus numerous other similar experiments, is
that inactivating the RNA-binding activity of any one RBD
had no effect on the actual positions where the IRESs
were cleaved by Fe(II)-BABE conjugated to the other (non-
mutated) RBDs. No cleavage bands were seen at new sites
where there were no cuts seen with control Fe(II)-PTB9
derivatives in which all four RBDs were active in RNA-
binding. This leads to the important conclusion that inacti-
vating one RBD does not perturb the orientation of binding
of PTB to the IRESs.
FIGURE 3. Primer extension analyses of directed hydroxyl radical probing experiments to test
for disruption of the interaction of mutated RBDs with the EMCV and PV IRESs. Assays of the
designated PTB9 mutants with the EMCV IRES are shown in panels A–H, with panels A,C,E,G
examining interactions with Domains D–F, and panels B,D,F,H, the interactions with Domains
G–K. Assays with the PV-1 IRES are in panels I–L. The cleavage products arising from Fe(II)
conjugated to the relevant non-mutated RBD are indicated by vertical lines to the left of the
reference standard lanes. The inactivating mutations analyzed in each subpanel are as follows:
A,B,I—RBD1 mutations; C,D,J—RBD2 mutations; E,F,K—RBD3 mutations; and G,H,L—RBD4
mutations. Lanes A,C,G are from sequencing ladders with the same primers as the primer
extension lanes. The arrowheads to the left of each panel indicate the position of the reference
standard cleavage site in the IRES.
Kafasla et al.
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However, in some cases inactivating
one RBD resulted in a clear reduction in
the intensity of the cleavage bands arising
from Fe(II) conjugated to some of the
non-mutated RBDs. Although there
appear to be enhancements of the
Fe(II)-RBD4A cleavage at EMCV nt 342
in Figure 2A (cf. lanes 12 and 6), the
Fe(II)-RBD4A cleavage at PV nt 447 in
Figure 2C (cf. lanes 9 and 6), and the
several Fe(II)-RBD2 cleavages of the PV
IRES in Figure 2C (cf. lanes 7 and 3), a
visual inspection (supported by quanti-
tation using the SAFA software as de-
scribed in Materials and Methods) of the
background bands in these lanes shows
that these apparent enhancements can be
explained by a slight underloading of the
reference standard lanes (Fig. 2A, lane 6;
Fig. 2C, lanes 3,6) and overloading of
lane 12 in Figure 2A and lanes 7 and 9 in
Figure 2C. When these considerations
were taken into account, we found no
evidence for any genuine enhancements
of cleavage band intensity.
The reduction in the intensity of some
of the cleavage bands arising from Fe(II)-
BABE conjugated to a non-mutated RBD
implies that over the 15-min duration
of the probing assay, the average position
of that particular non-mutated RBD
was more distant from the RNA than
when all four RBDs were active. One
possible but unlikely explanation is that
the non-mutated RBD was permanently
located for the 15-min period at a posi-
tion somewhat more distant from the
RNA than in the control in which all four
RBDswere active in RNA-binding. How-
ever, the more likely explanation is that
the particular non-mutated RBD was
fully engagedwith the RNA (i.e., as tightly
bound as in the controls) for relatively less
time and fully disengaged or dissociated
for longer. This raises the question of
whether the temporary dissociation of
one non-mutated RBD in this way will
lead to complete dissociation of the PTB
from the RNA, and this obviously de-
pends on whether there is simultaneous
dissociation of both of the other two non-
mutated RBDs. Nevertheless, complete
dissociation in these circumstances is
a real possibility warranting consider-
ation, given the indications that all four
FIGURE 4. Representative primer extension analyses of directed hydroxyl radical probing
experiments to test whether inactivation of one RBD affects the interaction of the other three
RBDs with the EMCV and PV IRESs. (A,C,E) Assays of interactions with the 59-proximal part
of the EMCV IRES, using mutants inactivated in RBD1 (panel A), RBD2 (panel C), and RBD4
(panel E). (B,D,F) Assays of interactions with the PV-1 IRES, using mutants inactivated in
RBD1 (panel B), RBD2 (panel D), and RBD3 (panel F). In each panel, the vertical line to the
left of the reference standard lane highlights the cleavage products generated (in the absence of
any inactivating mutations) by Fe(II) conjugated to the particular RBD under examination,
and they are repeated in all the other lanes assaying PTB9 derivatives with Fe(II) conjugated to
the same RBD. The arrowheads to the left of each panel indicate the reference standard
cleavage site position in the IRESs. Lanes C,G,T are from sequencing ladders using the same
primer. The cleavage band intensities in these and many other similar experiments were
quantitated as described in Materials and Methods, and the cleavage band intensity determined
for PTB9 derivatives with inactivating mutations in one RBD and Fe(II)-BABE conjugated to
one or more non-mutated RBDs was compared with that found for the corresponding
reference standard (WT) with no inactivating mutations (taken as 100%). The consensus of
the relative intensity values obtained from many such experiments, covering all three PTB
binding sites (two in the EMCV IRES and one in the PV IRES), is tabulated in a semi-
quantitative form at the bottom of the figure.
Mechanism of picornavirus IRES activation by PTB
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RBDs contribute to the binding of PTB to its target RNAs
(Simpson et al. 2004;Oberstrass et al. 2005), and, in particular,
the finding that deletion mutants which retain just two RBDs
have significantly lower binding affinity than full-length PTB
for the EMCV IRES (and also for a pre-mRNA target of PTB),
with the affinity of the RBD3+ 4 combination distinctly lower
than that of the RBD1 + 2 pair (Simpson et al. 2004).
If the reduced intensities in the cleavage bands arising from
Fe(II) conjugated to the non-mutated RBDs are entirely due
to complete dissociation of the PTB from the IRES, wewould
expect to see equivalent reductions in intensity for all three
non-mutated RBDs. By this criterion, the results suggest that
inactivating one RBD by introducing point mutations causes
very little complete dissociation of the PTB from the RNA,
because, for each inactivated RBD, there was at least one
non-mutated RBD that showed significantly less reduction
in cleavage band intensity than one (or both) of the other
two (as summarized in Fig. 4). In addition, with the D1
replacement of RBD1, there was no reduction in cleavage
band intensity arising from Fe(II)-RBD4A at EMCV nt 342
(Fig. 2A, lanes 6,9) or PV nt 447 (Fig. 2C, lanes 6,9), and
no reduction of the several Fe(II)-RBD2 cleavages on the PV
IRES (Fig. 2C, lanes 3,7), although reductions in intensity
were seen in the case of the Fe(II)-RBD2 cleavages on the
EMCV IRES (Fig. 2A, lanes 3,7) and, more especially, the
Fe(II)-RBD3 cleavage at EMCV nt. 300 (Fig. 2A, lanes 4,8).
We conclude that even though the inactivation of one
particular RBD may increase the susceptibility of one or two
specific non-mutated RBDs to dissociate from their usual
binding site(s) on the IRESs, it does not provoke a large
increase in the frequency of complete dissociation of the PTB.
Nevertheless, in order to examine this questionmore directly
and more quantitatively, we have done filter-binding assays,
using the full-length EMCV probe with Cys-less PTB9 as the
control and the four mutants with the group m, b, f, and k
mutations (Fig. 5). These assays gave the following average
Kd values (with standard deviations in parentheses): C-less
PTB9, 33 nM (69 nM); RBD1 mmutant, 46 nM (616 nM);
RBD2 b mutant, 65 nM (613 nM); RBD3 f mutant, 43 nM
(614 nM); and RBD4 kmutant, 34 nM (67 nM). This value
for the Cys-less PTB9 positive control is similar to those
reported previously for wild-type PTB (Kafasla et al. 2009).
In addition, the hierarchy of affinity of the inactivated
mutants, namely RBD4 k > RBD3 f > RBD1 m > RBD2 b,
is entirely consistent with the observation that a deletion
mutant which retains just RBDs3 and 4 (and therefore lacks
RBDs1 and 2) binds with significantly lower affinity than the
reciprocal deletion which retains just RBDs1 and 2 (Simpson
et al. 2004).
Assay of the mutants in translation assays of EMCV
and PV IRESs
Finally, we assessed the effect of disrupting the RNA-binding
potential of each RBD on the activity of PTB in stimulating
translation driven by the EMCV and PV-1 IRESs. The most
effective group of inactivating mutations in each RBD was
used for these assays, with wild-type full-length PTB as the
positive control. The maximum stimulation observed with
the PTB9 mutant was compared to the maximum observed
with the PTB-1 positive control and the background ob-
served with no added protein. The PTB9 mutants (and the
wild-type PTB-1 positive control) were added at 24, 47, 94, or
188 nM final concentration. Our previous work has shown
that, despite themodest reduction in binding affinity of some
of the inactivated mutants noted in the previous section,
a concentration of 188 nM should be sufficient to achieve
effective saturation with both IRESs (Kafasla et al. 2009,
2010), without the complication of the downturn in stimu-
lation seen at higher protein concentrations, especially with
the PV IRES (Kafasla et al. 2010), but also with the EMCV
IRES in some experiments (Fig. 7G, see below).
For the PV IRES, standard nuclease-treated reticulocyte
lysate was used, which contributes z40 nM endogenous
PTB to the assay (Kafasla et al. 2010), with a monocistronic
mRNA consisting of the complete PV 59UTR fused to a CAT
reporter. The results showed that inactivation of either
RBD1, RBD2, or RBD4 completely abrogated all stimulation
(Fig. 6C,D,F, respectively). By contrast, inactivation of
RBD3 had a much smaller effect (Fig. 6E), which is entirely
consistent with our previous results of tethered hydroxyl
FIGURE 5. Filter-binding assays of the interaction of various PTB9
derivatives with the full-length EMCV probe. The assay was performed in
triplicate as described in Materials and Methods. The average values for
the fraction of RNA bound to PTB9 are plotted against the concentration
of PTB9 derivative, which is plotted on a log10 scale. For clarity, error bars
have been omitted, and instead the standard deviations for the calculated
Kd values are given in the text.
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radical probing with Fe(II)-N395C (Kafasla et al. 2010) (see
Discussion).
For the EMCV IRES, we used a PTB-depleted lysate
(Kaminski et al. 1995) because the affinity of PTB for the
EMCV IRES is higher than for the PV-1 IRES, and yet the
stringency of the PTB-requirement is lower (Kaminski and
Jackson 1998). A monocistronic mRNA was used consisting
of the entire EMCV 59 UTR downstream from the poly(C)
tract (Duke et al. 1992) (i.e., from nt 260) fused to an
influenza virus NS reporter ORF, and the IRES sequence was
a mutant with an enlarged 7A-bulge at the three-way
junction between Domains J and K (Fig. 2B), because this
shows considerably higher PTB-dependency than the wild-
type IRES which has a 6A-bulge in this position (Kaminski
and Jackson 1998).
The results of these assays showed that inactivation of
RBD2 completely eliminated all stimulation by PTB, whereas
RBD1 inactivation had a considerably smaller negative effect
(Fig. 7C,D). Inactivation of either RBD3 or RBD4 caused
a z50% reduction (Fig. 7E,F), rather than complete abro-
gation of the PTB-dependent stimulation. In view of the
finding that RBDs3 and 4 can act as a coordinated pair, or
didomain (Oberstrass et al. 2005), and that Fe(II)-N395C in
RBD3 generates a strong cleavage in the apical loop of IRES
Domain H, while Fe(II)-E518C in RBD4
cuts in the neighboring Domains G and
the base of I (Kafasla et al. 2009), it
seemed possible that when either RBD3
or RBD 4 had been inactivated, binding
of the other (intact) RBD to this region of
the IRES could still result in some partial
stabilization of the three-dimensional
structure of the IRES, which is thought
to be the underlying explanation for the
stimulatory effect of PTB (Kafasla et al.
2009). We, therefore, tested the effect of
inactivating both RBDs3 and 4, which
had the outcome that stimulation of the
7A-bulge IRES was almost completely
abolished and could not be rescued by
raising the concentration of this PTB9
mutant to extremely high levels (Fig. 7G).
DISCUSSION
The important general conclusion is
that it is possible to selectively inactivate
the RNA-binding potential of any of the
RBDs in PTB by introducing no more
than three point mutations at strategi-
cally chosen positions. Moreover, inacti-
vating the RNA-binding of any one RBD
had no effect on the binding positions of
the other (non-mutated) RBDs on the
EMCV and PV-1 IRESs.
Although complete inactivation of RNA-binding required
three point mutations, it should be noted that there were
other derivatives with triple mutations that still retained
significant binding, notably the group l mutations in the
b2-strand of RBD1 and the group d mutations in the b4–b5
linker of RBD2 (data not shown). Thus, it is not just the
number of mutations that is the important determinant but
also their position, as well as perhaps the nature of the amino
acid substitutions. The most effective inactivating triple
mutations were either in the b2-strand (RBDs2 and 3) or
b4-strand (RBDs1 and 4). The NMR structures of each wild-
type RBD complexed with a CUCUCU hexanucleotide
ligand (Oberstrass et al. 2005) show that the amino acids
substituted in these triple mutants primarily contact the
two nucleotides at the core of the hexameric oligonucleo-
tide. Moreover, inspection of the ensemble of the 20 lowest
energy structures for each RBD (Oberstrass et al. 2005)
suggests that these contacts hold the core nucleotides in
place in the complex (by contrast, the outer nucleotides are
not fixed in position) and, therefore, probably contribute
significantly to RNA-binding.
The translation assay results show that, apart from the
RBD3mutant and the PV IRES, inactivation of any one RBD
generally reduces the stimulation of IRES activity, though to
FIGURE 6. Translation assays of the stimulation of PV-1 IRES activity by PTB9 derivatives
with mutations in the RNA-binding surface of each RBD. (A,B) Representative autoradio-
graphs showing the translation products synthesized in the presence of various concentrations
of the wild-type full-length PTB-1 control (WT) and the designated PTB9 mutants. (C–F)
Summary of translation assay results for the designated mutants of RBD1 (panel C), RBD2
(panel D), RBD3 (panel E), and RBD4 (panel F). The maximum translation product yield
obtained with each mutant was compared to the yield observed when no PTB was added to the
translation reaction (PTB; set at 1.0 and shown by the dashed horizontal line). The results
shown are the mean (with error bars showing standard deviations) of the values obtained for
each mutant in three independent experiments.
Mechanism of picornavirus IRES activation by PTB
www.rnajournal.org 1127
 Cold Spring Harbor Laboratory Press on July 1, 2011 - Published by rnajournal.cshlp.orgDownloaded from 
different extents according to which IRES is tested and which
RBD has been mutated. The decreased stimulation cannot
be explained simply by reduced affinity of the PTB9–IRES
interaction. Even in the case of the RBD2 bmutations, which
showed the greatest decrease in binding affinity (Fig. 5), we
calculate that at 188 nM added PTB9 derivative, 73% of the
input mRNA with the EMCV IRES will be associated with
this mutant PTB9, compared to 84% with the Cys-less PTB9
or wild-type PTB controls. Thus, reduced affinity of the
PTB–IRES interaction in the case of this
particular mutant could only account for
a z13% reduction in IRES stimulation,
whereas stimulation of both IRESs was
actually abrogated (Figs. 6D, 7D). It
follows that the decrease in IRES stimu-
lation seen with all the inactivated mu-
tants is due to loss of specific contacts
between the mutated RBD and the IRES
and not to a general decrease in PTB
binding to the IRES. This further implies
that PTB binding per se is not sufficient
to stimulate IRES functionality if the
missing RBD–IRES interaction plays a
critical role.
Our previous investigation of the
PV-1 IRES showed that, under conditions
in which stimulation by PTB is observed,
the IRES binds a single PTB, with RBDs1
and 2 binding to closely neighboring sites
in the basal half of IRES Domain V and
RBD4 in close proximity to the short
Domain IV–V linker. Initiation factor
eIF4G (or eIF4F) also binds to the basal
half of Domain V (de Breyne et al. 2009),
and we found that PTB caused a subtle
change in the orientation of eIF4G bind-
ing, either as a result of competition
between PTB and eIF4G for overlapping
binding sites or through PTB binding
remodeling the RNA structure of this
region (Kafasla et al. 2010). This reori-
entation of eIF4G is likely to play a piv-
otal role in the activation of the IRES by
PTB, and we would therefore expect at
least one of the two interactions (of
RBD1 and RBD2) with Domain V to be
critical. In fact, binding of both RBDs1
and 2 was clearly essential for IRES
activation, as the mutation of either
completely abrogated stimulation (Fig.
6C,D). This strong negative effect is un-
likely to be due to a secondary effect in
which the inactivation of one of these
RBDs destabilizes the binding of the
other, because neither the group m mu-
tations nor the complete D1 replacement reduced the
binding of RBD2 to Domain V (Fig. 2C, cf. lanes 3 and 7;
Fig. 4B), and the group b mutations in RBD2 caused only
a rather modest reduction in RBD1 binding to Domain V
(Fig. 4D). RBD4 bindingwas also found to be important (Fig.
6F), perhaps because its interaction with the Domain IV–V
linker places constraints on the relative spatial orientation of
these two large domains. On the other hand, the RBD3–IRES
interaction seemed superfluous (Fig. 6E). This is consistent
FIGURE 7. Translation assays of the stimulation of EMCV IRES activity by PTB9 derivatives
with mutations in the RNA-binding surface of each RBD. (A,B) Representative autoradio-
graphs showing the translation products synthesized in the presence of various concentrations
of the wild-type full-length PTB-1 control (WT) and the designated PTB9 mutants. (C–F)
Summary of translation assay results for the designated mutants of RBD1 (panel C), RBD2
(panel D), RBD3 (panel E), and RBD4 (panel F). The maximum translation product yield
obtained with each mutant was compared to the yield observed when no PTB was added to the
translation reaction (PTB; set at 1.0 and shown by the dashed horizontal line). The results
shown are the mean (with standard deviation) of the values obtained for each mutant in three
independent experiments. (G) Assay of wild-type full-length PTB (WT) and the C3C4A-fk
PTB9 derivative with inactivating mutations in both RBDs3 and 4. Translation products were
analyzed by SDS-PAGE, and the resulting autoradiograph is shown. The concentration of
added wild-type PTB or C3C4A-fk PTB9 in the assays is given above each lane, and the
numbers below each lane show the actual stimulation (i.e., the increment) in translation
product yield expressed relative to the yield (assigned a value of 1.0) in the control assay
lacking any added PTB or PTB9. The PTB-depleted lysate used for this experiment was
a different batch from that used for panels A–F, and the depletion was likely to have been more
efficient, resulting in a greater stimulation.
Kafasla et al.
1128 RNA, Vol. 17, No. 6
 Cold Spring Harbor Laboratory Press on July 1, 2011 - Published by rnajournal.cshlp.orgDownloaded from 
with the tethered hydroxyl radical probing results (Kafasla
et al. 2010), which showed that the strongest cleavage
generated by the Fe(II)-N395C derivative in RBD3 was only
a rather variable medium-weak cleavage just downstream
from Domain V, whereas Fe(II)-E518C (in RBD4) gave
a medium strength cut in the Domain IV–V linker, and the
RBD1 and RBD2 derivatives generated strong cleavages in
Domain V. From these data, we deduced that RBD3 is not in
close contact with the PV IRES (Kafasla et al. 2010), and thus,
it is hardly surprising that disrupting its RNA-binding
potential has such a minor effect on stimulation of IRES
activity.
In the only previous publication relevant to this issue,
where poliovirus IRES activity in transfection assays showed
significant stimulation when cotransfected with a wild-type
PTB expression construct, a PTB-1 derivative lacking RBD1
not only failed to stimulate but in fact quite strongly
inhibited the basal IRES activity sustained by the endogenous
PTB (Back et al. 2002). This implies that the lack of RBD1
does not perturb PTB binding to its usual site on the PV-1
IRES but does inhibit its functionality, which is entirely
consistent with our results. Overexpression of derivatives
comprising just RBDs1 and 2, or just RBDs3 and 4, also failed
to stimulate, but in both these cases, the inhibitory effect was
much weaker, suggesting that binding affinity was consider-
ably reduced (Back et al. 2002).
In our previous study of PTB binding to the EMCV IRES,
we found that the complete 59 UTR downstream from the
poly(C) tract (as shown in Fig. 2B) bound two PTBs, but the
core IRES, which has Domain H at its 59-end, bound a single
PTB, with RBDs1 and 2 binding to closely neighboring sites
in the distal part of Domain K, RBD3 binding strongly to
the apex of Domain H, and RBD4 interacting with the base
of Domain I, as well as with Domain G when the target RNA
was the complete 59 UTR (Kafasla et al. 2009). It was sug-
gested that this would place limits on the distance separating
the apex of Domain K from Domains G, H, and the base of
Domain I, thus constraining the three-dimensional structure
of the IRES to one more favorable for internal initiation. We
would, therefore, expect that the interaction of at least two
RBDs with the RNA would be essential, one at the Domain
K site and the other in the 59-proximal region. In fact, we
found that mutation of RBD2 had the greatest negative effect
(Fig. 7D), and it appears that the interaction of PTB with
Domain K is more critically dependent on RBD2 than RBD1
(Fig. 7C). The importance of the other two RBDs is more
complicated. Althoughmaximum stimulation required both
RBD3 and RBD4, inactivation of either one of them only
reduced the stimulation byz50%, suggesting the possibility
of some partial redundancy between them (Fig. 7E,F). This
suggestion is supported by the fact that almost no stimula-
tion was seen in the presence of the double mutation, not
even when its concentration was raised to extremely high
levels (Fig. 7G). A possible explanation is that the binding of
just one RBD (either RBD3 or RBD4) to the 59-end of the
core IRES does not constrain the three-dimensional flexibil-
ity of the IRES as effectively as when both interactions are
occurring.
A previous report on the stimulation of the FMDV IRES
(which is structurally similar to the EMCVcore IRES) by PTB
deletion mutants found that deletion of RBD1 had no
discernible effect (Song et al. 2005), and deletion of RBD2,
or both RBDs1 and 2, reduced stimulation by <50%, far less
than observed here with point mutations inactivating RBD2.
On the other hand, deletion of RBD3 or RBD4 almost
eliminated all stimulation, particularly the RBD4 deletion.
The authors concluded that RBDs3 and 4 were sufficient for
stimulation (Song et al. 2005), in contrast to our conclusions
for the EMCV IRES.
It is quite possible that this apparent discrepancy reflects
a genuine difference between the two IRESs, because our
previous study (Kaminski et al. 1995) of similar PTB deletion
mutants (tested as GST–PTB fusion proteins) gave results
remarkably consistent with those we have reported here. In
sharp contrast to the FMDV results (Song et al. 2005),
a deletion mutant which retained just RBDs3 and 4 failed
to stimulate the EMCV IRES (with a 7A-bulge at the Domain
J–K three-way junction) but did bind to this IRES, according
to the results of UV-cross-linking assays, and this was
confirmed by the fact that it inhibited stimulation by full-
length wild-type GST-PTB. Precisely the same results were
found for a mutant that retained just RBDs1 and 2. The
deletionmutant which showed by far the highest stimulation
of the EMCV IRES (z60% with respect to wild-type GST-
PTB) was one with just RBD1 deleted, consistent with our
conclusion that RBD1 binding is of relatively marginal
importance. Very weak stimulation was seen with a PTB
mutant that had intact RBDs1, 2, and 3, with a deletion of the
C-terminal 27 amino acids which removes part of RBD4
(including the whole b4-strand), and this mutant also
inhibited stimulation by wild-type GST-PTB. The negative
effect of this mutation on stimulation was, therefore, greater
than we found with our RBD4 point mutants (Fig. 7F), but
this difference could well be due to a type of dominant
negative effect exerted by the truncated RBD4. Apart from
this disagreement, the results we obtained previously with
these deletion mutants (Kaminski and Jackson 1998) and
with the point mutations described here lead to very similar
conclusions: RBD2 binding is essential for stimulation of the
EMCV IRES, RBD1 is of relatively minor significance, and
maximum stimulation needs both partners of the RBD3/
RBD4 didomain.
While this agreement is highly satisfactory, the potential
caveats and artifacts associatedwith extensive deletionsmake
it preferable that point mutants of the type developed here
should be exploited for further investigations into the
significance of each RBD for biological activity. Together
with our single cysteine PTB derivatives for use in directed
hydroxyl radical probing (Kafasla et al. 2009), a complete set
of reagents is now available for detailed investigation of the
Mechanism of picornavirus IRES activation by PTB
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interaction of PTBwith its other RNA targets, such as cellular
mRNA IRESs or pre-mRNAs which are subject to PTB-
regulated alternative splicing. Moreover, the approaches we
have used should be applicable to the analysis of any other
protein with multiple RBDs (for example, proteins of either
the RNP1/RNP2 or KH-domain families), particularly those
cases where structural data on the RBD complexed with an
RNA ligand are available.
MATERIALS AND METHODS
Construction of PTB9 mutants
The construction of expression plasmids encoding PTB9 (a
cysteine-less PTB-1 derivative lacking the N-terminal 54 amino
acids) and single cysteine derivatives of PTB9, the isolation of these
N-terminally hexahistidine-tagged recombinant PTB9 mutant pro-
teins, and their conjugation with Fe(II)-BABE have been described
previously (Kafasla et al. 2009). Groups of up to three mutations in
the RNA-binding surface of each RBD of PTB9 were introduced,
usually with a single mutagenic oligonucleotide, using a standard
(DpnI-dependent) site-directed mutagenesis protocol. To combine
different mutation groups into the same RBD, a multichange
mutagenesis protocol was used, either the Stratagene Multi Site
Mutagenesis kit, or an in-house adaptation of this method. The
appropriate reference cysteine (Fig. 1C) was then introduced into
the same RBD by site-directed mutagenesis. These mutations were
subsequently combined with single cysteines in other RBDs by
making use of the unique restriction enzyme sites in the inter-
RBD linkers (Kafasla et al. 2009). In every case, the mutations
were verified by sequencing the whole ORF.
Tethered hydroxyl radical probing assays
The preparation of the EMCV IRES RNA (nt 260–848, and with
a wild-type 6A-bulge at the Domain J–K three-way junction) was
as described previously (Kafasla et al. 2009), and the PV IRES
RNA (nt 94–630) was prepared as described in Kafasla et al.
(2010). Standard conditions for tethered hydroxyl radical probing
were 50 nM EMCV IRES RNA and 100 nM Fe(II)-PTB9 deriv-
ative, or 100 nM PV-1 IRES RNA with 700 nM Fe(II)-PTB9. The
procedure was as described previously (Kafasla et al. 2010), except
that the binding buffer for the EMCV IRES assays was 100 mM in
KCl, rather than the 70 mM as used for the PV IRES (Kafasla et al.
2010). Following initiation of the Fenton reaction by adding
ascorbic acid and H2O2, incubation was for 15 min on ice with
both RNA probes before re-isolation of the RNA by phenol
extraction. Primer extension analysis using AMV-RT was carried
out as described previously (Kafasla et al. 2010), using primers
PVpr5 and PVpr6 (described therein) in the case of the PV IRES
and the following primers for the EMCV IRES:
EMCVpr1: 59-GACCCCTAGGAATGCTCGTC-39;
EMCVpr2: 59-GTCTTCAAGAAGCTTCCAGAG-39;
EMCVpr6: 59-GTTGTGGCCATATTATC-39.
For quantitative analysis of cleavage bands, SAFA (Semi-
Automated Footprinting Analysis) software (Das et al. 2005;
Laederach et al. 2008) was used as described previously (Kafasla
et al. 2010). To compensate for possible variations in loading, the
band intensity values generated by the SAFA software were first
normalized with respect to background bands, whose intensity
was largely invariant in all lanes (including the Cys-less control lane)
but sometimes fluctuated in a few lanes in parallel with each other
(and with the full-length primer extension product when it was
visible). This normalized intensity for each individual band in a given
experimental lane was then compared, as a ratio, to the intensity of
the corresponding normalized band in the Cys-less control lane.
Filter-binding assays
The affinity of the various PTB mutants for 32P-labeled EMCV
IRES RNA (nt 260–848) was assessed using filter-binding assays.
PTB–RNA complexes were assembled by incubation for 20 min at
room temperature in 50 mL reactions in 10 mM HEPES pH 7.4,
100 mM KCl, 2.5 mM MgCl2, 5% glycerol, 1 mM DTT, 50 mg/mL
yeast tRNA, 50 mg/mL bovine serum albumin, and 8 nM probe
RNA. Assays were performed using the protein-binding Protran
NBA-085B nitrocellulose membrane (Whatmann) to immobilize
the PTB–RNA complexes and a lower layer of Hybond-N
membrane (Amersham Life Sciences) to immobilize the unbound
free RNA. The membranes were washed extensively in 10 mM
HEPES pH 7.4, 2.5 mM MgCl2, 5% glycerol, 1 mM DTT and
mounted on a 96-well dot-blotter. Before and after application of
45 mL of the binding reaction, the membrane was washed with
180 mL of wash buffer. Following the experiment, the membrane
was dried, and the fraction of input RNA bound to PTB was
determined by densitometric analysis of the autoradiograph using
TotaLab TL120 software (Nonlinear Dynamics).
In vitro translation assays
Uncapped monocistronic mRNA with the PV-1 IRES (nt 1–747)
fused in frame with a CAT ORF was prepared by transcription
with T7 RNA polymerase as described previously (Kafasla et al.
2010). The translation assay reactions contained 60% (by volume)
standard nuclease-treated rabbit reticulocyte lysate, and the
following additional components at the final concentration stated:
10 mM haemin, 50 mg/mL creatine kinase, 10 mM creatine
phosphate, 0.1 mM each amino acid (except methionine), 70
mM KCl, 0.5 mM MgCl2, 4 mM 2-aminopurine and [
35S]methi-
onine. The standard mRNA concentration was 12 nM mRNA, and
PTB9 derivatives (or wild-type PTB-1 positive control) were added
at 23.5, 47, 94, or 188 nM. Incubation was at 30°C for 60 min,
then the products were separated by SDS-PAGE, and the yield of
the full-length product band was quantified. The maximum
stimulation observed with the PTB9 derivatives was compared
with the maximum seen with the PTB-1 control.
Uncapped monocistronic mRNA with the EMCV IRES (nt
260–846 and with an enlarged 7A-bulge at the Domain J–K three-
way junction) fused to the influenza virus NS1 ORF was prepared
by transcription with T7 polymerase of plasmid pEMCV-NS
(Kaminski and Jackson 1998) that had been linearized with Eco
RI. It was translated in nuclease-treated reticulocyte lysate that
had been depleted of PTB by the procedure described previously
(Kafasla et al. 2009). Translation assay conditions were otherwise
as stated above except that the final concentration of added KCl
was 100 mM. The standard mRNA concentration was 20 nM, with
PTB9 derivatives or wild-type PTB-1 at the same concentrations as
for the mRNA with the PV IRES.
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